Near-infrared fluorescence-guided oncologic surgery (FGOS) with the use of a tumor specific
tracer (SGM-101) developed by Surgimab can provide valuable intra-operative information about
tumor location and extensiveness. SGM-101 already proven to be safe and valuable in
colorectal cancer.
This study aims to prove feasibility for colorectal lung metastases.